decreased circulating cholesterol level_Apoe<tm1(APOE)Kyan>/Apoe<tm1(APOE)Kyan>

http://metadb.riken.jp/0005179I129P2OlaHsdApoetm1APOEKyanApoetm1APOEKyanApoetm1APOEKyan

decreased circulating cholesterol level_Apoe<tm1(APOE)Kyan>/Apoe<tm1(APOE)Kyan>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• apolipoprotein E
  http://metadb.riken.jp/db/mgi_rdf/MGI:88057

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apoe<tm1(APOE)Kyan>/Apoe<tm1(APOE)Kyan>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Apoe<tm1(APOE)Kyan>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating cholesterol level
  http://purl.obolibrary.org/obo/MP_0005179

文献

http://purl.org/net/cito/citesAsAuthority

• Takashi. Mori, et.al., Increased vulnerability to focal ischemic brain injury in human apolipoprotein E4 knock-in mice., Journal of neuropathology and experimental neurology, 2003, 62
  http://rdf.ncbi.nlm.nih.gov/pubmed/12638732